Photo: John Lamparski/Getty Images

Former Georgia gubernatorial candidate Stacey Abrams won't run for the state's Senate seat in 2020, telling the Atlanta Journal-Constitution that her "responsibility is not simply to run because the job is available."

The intrigue: Abrams' decision to pass on a Senate run will heighten speculation that she could jump into the crowded field of Democrats running for president in 2020. She's also a hot contender for a vice presidential slot and had been considered by former Vice President Joe Biden's campaign as his out-of-the-gate running mate.

Go deeper: Stacey Abrams commends Biden for recognizing harassment claims

Go deeper

Ina Fried, author of Login
24 mins ago - Technology

Candidates go online to cut through debate noise

Photo: Saul Loeb/AFP via Getty Images

While President Trump and Joe Biden fought to be heard in a rowdy debate Tuesday, both campaigns sought to draw digital battle lines and occupy online turf they could have all to themselves.

The big picture: Trump's impulsive Twitter style made a shambles of the debate format, but online the candidates were able to find niches where they couldn't be interrupted — and could motivate their supporters to donate, organize and turn out to vote.

Ben Geman, author of Generate
1 hour ago - Energy & Environment

Shell plans up to 9,000 job cuts by 2022

A Shell station in Brazil. Photo: Rafael Henrique/SOPA Images/LightRocket via Getty Images

Royal Dutch Shell will shed up to 9,000 jobs as it undergoes a long-term restructuring around climate-friendly energy sources and continues to grapple with the coronavirus pandemic that has battered the oil industry.

Why it matters: The cuts could amount to over 10% of the company's global workforce, which was 83,000 at the end of 2019.

Caitlin Owens, author of Vitals
1 hour ago - Health

The coronavirus' alarming impact on the body

Illustration: Eniola Odetunde/Axios

Scientists are racing to learn more about the damage the novel coronavirus can do to the heart, lungs and brain.

Why it matters: It’s becoming increasingly clear that some patients struggle with its health consequences — and costs — far longer than a few weeks.